Literature DB >> 3789252

An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component.

Y Sato, S Watanabe, K Mukai, T Kodama, M P Upton, M Goto, Y Shimosato.   

Abstract

The cellular composition and characteristics of lymphocytes and histiocytes in nine cases of thymoma and one case of squamous cell carcinoma of the thymus were studied immunohistochemically, using a panel of monoclonal and polyclonal antibodies. Nine cases of thymoma were subclassified into seven cases of mixed type and one case each of predominantly lymphocytic type and predominantly epithelial type. Two metastatic tumors and one recurrent tumor were included. Almost all the lymphocytes in the mixed type and lymphocytic type categories, either in primary site or metastasis, were T lymphocytes which showed the immature thymic lymphocyte-phenotype of the normal thymic cortex. On the other hand, the one epithelial thymoma contained many mature T lymphocytes along with immature T cells, as in the normal thymic medulla. In thymic squamous cell carcinoma, all infiltrating T lymphocytes were mature T lymphocytes. These findings suggest that epithelial cells of thymomas have an intimate relationship with the coexisting lymphocytes and retain functional properties of the normal thymic epithelial counterpart. On the other hand, the specific function of thymic epithelial cells is no longer maintained in thymic squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789252     DOI: 10.1097/00000478-198612000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.

Authors:  Thaer Khoury; Rameela Chandrasekhar; Gregory Wilding; Dongfeng Tan; Richard T Cheney
Journal:  Int J Exp Pathol       Date:  2010-11-02       Impact factor: 1.925

Review 2.  Peripheral T-cell lymphoma.

Authors:  S Watanabe; K Mukai; M Shimoyama
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

3.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.

Authors:  H Asamura; T Nakajima; K Mukai; M Noguchi; Y Shimosato
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  High frequency of p53 protein expression in thymic carcinoma but not in thymoma.

Authors:  N Hino; K Kondo; T Miyoshi; T Uyama; Y Monden
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Invasive thymoma with endobronchial polypoid growth.

Authors:  K Kondo; T Uyama; M Sumitomo; K Takahashi; S Kimura; Y Monden
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

Review 7.  Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment.

Authors:  Christos Masaoutis; Kostas Palamaris; Stefania Kokkali; Georgia Levidou; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

8.  Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Authors:  David Suster; James A Miller; German Pihan; A Craig Mackinnon; Saul Suster
Journal:  Mod Pathol       Date:  2021-06-16       Impact factor: 7.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.